50% off Premium Yearly

TSE:GIB.A
This summary was created by AI, based on 20 opinions in the last 12 months.
CGI Group (GIB.A-T) is facing challenges amid a slowdown in earnings growth and concerns related to AI's impact on consulting services. Experts note that the company has been affected by factors such as the US government shutdown and a general decline in the tech sector, leading to negative organic growth. However, many believe that the current selling pressure is overdone, with some analysts emphasizing the company's strong balance sheet, long-term contracts, and potential for future growth through strategic acquisitions. While the stock hasn't been performing well, several analysts argue that CGI Group remains a solid investment due to its stability and recurring revenue model, particularly as it helps businesses adapt to AI technology.
They had the issue with the US healthcare software but this year it has held up well. If we get much below this $32 area it would be bad technically. The insider selling is a huge negative. You never know why an insider is selling, but it is much better if they are buying. The company is not buying back stock, so it suggests it is breaking down.
(A Top Pick June 11/13. Up 21.18%.) Their Logica acquisition has been largely integrated in terms of restructuring and cutting costs. They are now in the transformation stage where they are getting out of lower margin businesses, and getting new higher-margin businesses. The highest book to bill in the last quarter was in Europe, indicating they are garnering new business. Trading at a very reasonable multiple of the 11-12 times earnings.
Obama care and some accounting issues have been the bugaboos lately. Going back to the Obama care situation and analyze it, you find the problem really wasn’t this company. They weren’t given enough time to do the job they were supposed to do. The US government is a very small percentage of what this company does. Fantastic company.
Basically a software firm that contracts out, largely to governments. Got badly tarnished with the Obama care in the US which was largely overblown. Feels they are very well managed overall with a good, long-term growth strategy. On a multiple basis, it still looks expensive. If it were to pull back another 10%, he would be quite interested in looking at it.
(A Top Pick March 11/14. 2.77%.) This was a little bit of a contrarian pick. They got a little bit hammered when they left the Obama contract a number of months ago, but since that date they have landed a new US government contract. It is holding, even though it is not making new highs. It is generally following its upward trend line.
It broke down on July 7th. It is in the right space and above all its moving averages. He would rather wait for it to go up higher before buying, but hold if you own it now. A well run company.